Showing results (361-370 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|October 1, 1992
Regulation of human alcohol dehydrogenase genesH J Edenberg, C J BrownPharmacogenetics|March 6, 2003
The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirementJan van der Weide, Linda S Steijns, Marga J van WeeldenPharmacogenetics|May 2, 2003
Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopeniaLena E Carlsson, Norbert Lubenow, Carmen Blumentritt, et al.Pharmacogenetics|May 2, 2003
A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophreniaMasanari Itokawa, Kazuo Yamada, Kiyoshi Yoshitsugu, et al.Pharmacogenetics|December 1, 1994
Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancerT Okada, K Kawashima, S Fukushi, et al.Pharmacogenetics|June 1, 1994
Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsA Gaedigk, S P Spielberg, D M GrantPharmacogenetics|October 1, 1994
Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humansM T Landi, P A Bertazzi, P G Shields, et al.Pharmacogenetics|November 1, 1991
Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effectL Lin, F Yang, Z Ye, et al.Pharmacogenetics|July 13, 2004
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivityDyfrig A Hughes, F Javier Vilar, Charlotte C Ward, et al.Pharmacogenetics|July 13, 2004
Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphismsAlastair Sandilands, Giles Yeo, Morris J Brown, et al.Pageof 83